Shenzhen Chipscreen Biosciences Co., Ltd.

SHSE:688321 Stock Report

Market Cap: CN¥8.1b

Shenzhen Chipscreen Biosciences Balance Sheet Health

Financial Health criteria checks 2/6

Shenzhen Chipscreen Biosciences has a total shareholder equity of CN¥1.7B and total debt of CN¥1.1B, which brings its debt-to-equity ratio to 66%. Its total assets and total liabilities are CN¥3.2B and CN¥1.5B respectively.

Key information

66.0%

Debt to equity ratio

CN¥1.12b

Debt

Interest coverage ration/a
CashCN¥620.15m
EquityCN¥1.69b
Total liabilitiesCN¥1.52b
Total assetsCN¥3.21b

Recent financial health updates

Recent updates

We Think Shenzhen Chipscreen Biosciences (SHSE:688321) Has A Fair Chunk Of Debt

Jun 04
We Think Shenzhen Chipscreen Biosciences (SHSE:688321) Has A Fair Chunk Of Debt

Investors Appear Satisfied With Shenzhen Chipscreen Biosciences Co., Ltd.'s (SHSE:688321) Prospects As Shares Rocket 26%

Apr 24
Investors Appear Satisfied With Shenzhen Chipscreen Biosciences Co., Ltd.'s (SHSE:688321) Prospects As Shares Rocket 26%

Solid Earnings May Not Tell The Whole Story For Shenzhen Chipscreen Biosciences (SHSE:688321)

Apr 05
Solid Earnings May Not Tell The Whole Story For Shenzhen Chipscreen Biosciences (SHSE:688321)

Shenzhen Chipscreen Biosciences Co., Ltd.'s (SHSE:688321) Shares Climb 30% But Its Business Is Yet to Catch Up

Mar 06
Shenzhen Chipscreen Biosciences Co., Ltd.'s (SHSE:688321) Shares Climb 30% But Its Business Is Yet to Catch Up

Financial Position Analysis

Short Term Liabilities: 688321's short term assets (CN¥1.1B) exceed its short term liabilities (CN¥352.4M).

Long Term Liabilities: 688321's short term assets (CN¥1.1B) do not cover its long term liabilities (CN¥1.2B).


Debt to Equity History and Analysis

Debt Level: 688321's net debt to equity ratio (29.3%) is considered satisfactory.

Reducing Debt: 688321's debt to equity ratio has increased from 31.8% to 66% over the past 5 years.

Debt Coverage: 688321's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: Insufficient data to determine if 688321's interest payments on its debt are well covered by EBIT.


Balance Sheet


Discover healthy companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.